Tuesday, May 28, 2019 5:30:37 PM
Quick synopsis on how big this merger is.
Global Stem Cells Group combines six major medical corporations, each focused on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments and training, while adhering to the highest medical standards.
Revenues 29 million. 145 Employees.
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
Global Stem Cells Group founder and CEO Benito Novas received Accredited Member status and International leadership award from Cartagena University and International Society in Research, Health, Business Development and Technology at the III International Medical Scientific and Business Development Congress Nov. 24, 2018 at Cartagena University in Colombia.
Novas received recognition as a high-scale marketer with proven leadership in the management of operations in the health sector as head of Global Stem Cells Group, a U.S.-based group of regenerative medicine companies with a permanent presence in 26 countries that includes training and business operations in the areas of cell therapies and tissue engineering.
Ming Zhang Jie, MD
Ming Zhang Jie, M.D. is Chairman of HANK Bioengineering Co. LTD., a biotechnology company based in Shenzhen, China that focuses on the integration of research, development, production and sale of biomedical products.
Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA for outstanding achievement in natural murderers (NK) cell research in 2012, and has earned numerous awards for his work in the field of HIV, HCV, West Nile virus, the Japanese encephalitis virus, and quality performance.
Dr. Zhang launched HANK Bioengineering in 2013, a 4,300 square foot CFDA cGMP certified facility affiliated with the Institute of Cell Biology and Bioengineering, HANK Molecular Immunology Laboratory.
http://www.stemcellsgroup.com/
Global Stem Cells Group combines six major medical corporations, each focused on furthering the industry’s scientific and technological advancements to lead cutting edge stem cell development, treatments and training, while adhering to the highest medical standards.
Revenues 29 million. 145 Employees.
https://www.zoominfo.com/c/global-stem-cells-group-inc/357592775
Global Stem Cells Group founder and CEO Benito Novas received Accredited Member status and International leadership award from Cartagena University and International Society in Research, Health, Business Development and Technology at the III International Medical Scientific and Business Development Congress Nov. 24, 2018 at Cartagena University in Colombia.
Novas received recognition as a high-scale marketer with proven leadership in the management of operations in the health sector as head of Global Stem Cells Group, a U.S.-based group of regenerative medicine companies with a permanent presence in 26 countries that includes training and business operations in the areas of cell therapies and tissue engineering.
Ming Zhang Jie, MD
Ming Zhang Jie, M.D. is Chairman of HANK Bioengineering Co. LTD., a biotechnology company based in Shenzhen, China that focuses on the integration of research, development, production and sale of biomedical products.
Dr. Zhang is an accomplished scientist, microbiologist and virologist who has worked extensively in the U.S. for the CDC, the National Institutes of Health (NIH) and the US Food and Drug Administration in various research positions, including senior associate at the National Research Center. A Chinese-American, Dr. Zhang received the Award for Scientific Achievement from the FDA for outstanding achievement in natural murderers (NK) cell research in 2012, and has earned numerous awards for his work in the field of HIV, HCV, West Nile virus, the Japanese encephalitis virus, and quality performance.
Dr. Zhang launched HANK Bioengineering in 2013, a 4,300 square foot CFDA cGMP certified facility affiliated with the Institute of Cell Biology and Bioengineering, HANK Molecular Immunology Laboratory.
http://www.stemcellsgroup.com/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
